Helix 12 directed steroidal pharmaceutical products

Details for Australian Patent Application No. 2012202756 (hide)

Owner Endorecherche, Inc.

Inventors Labrie, Fernand; Singh, Shankar; Gauthier, Sylvain; Frechette, Yvon; Chenard, Sylvain; Breton, Rock

Agent Griffith Hack

Pub. Number AU-A-2012202756

Parent 2009202038

Filing date 10 May 2012

Wipo publication date 31 May 2012

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 35/00 (2006.01) Antineoplastic agents

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

24 May 2012 Complete Application Filed

31 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202756

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202757-Device for sterilization of fluid phase

2012202755-Ocular therapy using alpha-2 adrenergic receptor agonists having enhanced anterior clearance rates